Korro Bio, Inc./$KRRO
1D1W1MYTD1Y5YMAX
Capital at risk
About Korro Bio, Inc.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability. The company operates and manages its business as one reportable segment and one operating segment, which is the business of discovering, developing and commercializing therapies derived from or incorporating its RNA-editing technology.
- Ticker
- $KRRO
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 57
- Headquarters
- Cambridge, United States
- Website
- www.korrobio.com
Korro Bio, Inc. Metrics
BasicAdvanced
$174M
-
-$8.88
2.21
-
Price and volume
Market cap
$174M
Beta
2.21
52-week high
$55.89
52-week low
$5.20
Average daily volume
119K
Financial strength
Current ratio
9.553
Quick ratio
9.11
Long term debt to equity
0.381
Total debt to equity
0.409
Interest coverage (TTM)
-89.63%
Profitability
EBITDA (TTM)
-74.326
Gross margin (TTM)
-1,722.25%
Net profit margin (TTM)
-4,477.08%
Operating margin (TTM)
-3,228.34%
Effective tax rate (TTM)
-0.79%
Revenue per employee (TTM)
$40,000
Management effectiveness
Return on assets (TTM)
-27.95%
Return on equity (TTM)
-97.69%
Valuation
Price to revenue (TTM)
59.519
Price to book
1.68
Price to tangible book (TTM)
1.68
Price to free cash flow (TTM)
-2.077
Free cash flow yield (TTM)
-48.15%
Free cash flow per share (TTM)
-5.682
Growth
Revenue change (TTM)
-62.08%
Earnings per share change (TTM)
-9.04%
3-year earnings per share growth (CAGR)
-9.97%
Upcoming events
No upcoming events
Funds containing Korro Bio, Inc.
Fund name | Fund size | $KRRO weighting |
|---|---|---|
SPDR Russell 2000 US Small Cap€R2US | €4.8B | 0.01% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.